glp 1 and glp 2 Glucagon Like Peptide Receptor - an overview GLP-1 receptor agonists | How

When this happens, it stimulates insulin and lowers glucagon, both of which have the effect of lowering your blood sugar

This ability to address cardiovascular disease adds another compelling reason for their widespread adoption

References 1.Andreasen C.R., Andersen A., Knop F.K., Vilsbll T

Here are three valuable resources I recommend: American Diabetes Association (ADA) : Their website offers comprehensive guidelines and research updates on GLP-1 therapies, ideal for both patients and providers

The safety and glycaemic efficacy of tirzepatide as an additional treatment for Japanese subjects with T2D who were not achieving adequate glycemic control with various oral antihyperglycaemic monotherapies (SURPASS-J combo trial) were similar to those observed in the SURPASS-J mono trial [141]

The GLP-1 group had notably lower rates of death and major cardiac events